Virtual Roundtable on States Experiences Screening for Spinal - PowerPoint PPT Presentation

Virtual Roundtable on States’ Experiences Screening for Spinal Muscular Atrophy (SMA) Maryland SCID/SMA Multiplex Assay Drs. Fizza Gulamali-Majid and Jennifer Taylor Maryland Department of Health Newborn Screening Division 10/24/19

Screening Method • Method developed at CDC • PCR performed with 2-mm DBS punch in PCR plate • TREC and SMN1 (exon 7) multiple assay • RNaseP (RPP30) is used as a reference gene • AriaMX real-time PCR instrument • Biomek NXp is used to process the plates • Analytical Considerations • No increase in retest rate with the addition of SMA • Most specimens that are inconclusive for SMA are inconclusive for SCID

Screening Algorithm 3

SMA Screening Results • Started Screening May 31 st , 2019 • Screened over 57,894 specimens • Screened over 31,914 infants • 3 cases sent to follow-up • All 3 cases had no amplification of SMN1 exon 7 in the initial and repeat specimen • Case 1: SMA type 1 and was treated with Zolgensma • Case 2: Diagnosed with SMA, but currently presymptomic • Case 3 is pending • Screen-positive infants are seen at John Hopkins Hospital, Pediatric Neurology • No known false negatives 4

SMA Screening in Minnesota Carrie Wolf October 24, 2019

SMA in Minnesota Year Newborns Screened SMA Positive Screen SMA Confirmed (Screening began 3/1/18) 2018 (3/1/18 – 12/31/18) 55,871 8 8 2019 (through 10/1/19) 49,597 2 2 Total 105,468 10 10 SMA birth prevalence in Minnesota = 1:10,547 SMA Case Summary: -SMN1: 0 copies (n=10) -SMN2: • 2 copies (n=5) • 3 copies (n=3) • 4 copies (n=2) All 10 have started treatment with Spinraza with a couple also receiving Zolgensma. • Median time from birth to first injection = 19 days (range, 11 – 64 days)

SMA Algorithm SMA Screen (qPCR) Positive Inconclusive WNL SMN1 ≥ 30.00 SMN1 ≥ 30.00 or UND SMN1 < 30.00 and RNaseP Cq < 28.00 and RNaseP Cq ≥ 28.00 and RNaseP Cq < 28.00 Request a repeat Refer to diagnostic dried blood spot https:// www.health.state.mn.us/people/newbornscreening/materials/factsheets/bloodspotdisorders.html

SCID Algorithm SCID Screen (qPCR) Urgent Positive Inconclusive Positive WNL TREC MoM ≥ 1.200 or TREC MoM ≥ 1.100 or TREC MoM 1.100 - 1.199 TREC MoM < 1.100 UND UND and RNaseP Cq < 28.00 and RNaseP Cq < 28.00 and RNaseP Cq < 28.00 and RNaseP Cq > 28.00 Positive < 2000 grams Repeat Inconclusive Positive ≥ 2000 grams Refer to diagnostic Request a repeat Request a repeat Refer to diagnostic dried blood spot dried blood spot https:// www.health.state.mn.us/people/newbornscreening/materials/factsheets/bloodspotdisorders.html

Virtual Roundtable on States Experiences Screening for Spinal - PowerPoint PPT Presentation

Virtual Roundtable on States Experiences Screening for Spinal Muscular Atrophy (SMA) Maryland SCID/SMA Multiplex Assay Drs. Fizza Gulamali-Majid and Jennifer Taylor Maryland Department of Health Newborn Screening Division 10/24/19

Chemspace Virtual Screening Set Description Virtual screening (VS) has been a tool to identify

EXPERIENCES FROM SHARING AN AUTODOCK VINA WORKFLOW FOR VIRTUAL SCREENING USING THE SHIWA

Gaussian ensemble screening (GES): A new Gaussian ensemble screening (GES): A new approach to

Roundtable presentation by the UK Emissions Trading Group (ETG) 1. Introduction to the ETG

based virtual screening Peter Willett, University of Sheffield Computers in Scientific Discovery

VIRTUAL STUDYING AND TEACHING CHALLENGES STUDENTS AND TEACHERS RESULTS AND EXPERIENCES FROM A

Benchmarking in Federal Systems: Australian and International Experiences Joint Roundtable of the

1 2 3 4 5 F I N A N C I A L P R O T E C T I O N S S E R V I C E SCREENING The Screening

Experiences of the Virtual Experiences of the Virtual Community Grid Workgroup

Experiences booting one million virtual machines (and a few tools we developed) Ron Minnich Don

Screening for Specific Experiences: Fine- Tuning Questions in Multi-phase Testing Mandi Martinez

Analysis, and Virtual Screening Gaspar Pinto @ EJIBCE 2018 Introduction Who we are Praha

1 Methodology 1. Calculating spherical harmonic shapes Surface shapes are represented as radial

Boos$ng Virtual Screening Enrichments Using Data Fusion Coalescing

Focused Virtual Screening Lead discovery in the Human Estrogen Receptor a presentation by Dr

Accelerating Virtual High-Throughput Ligand Docking Screening One Million Compounds Using a

Managing Spinal Muscular Atrophy Nancy Kuntz, MD Professor of Pediatrics and Neurology,

Diagnosing Spinal Muscular Atrophy Nancy Kuntz, MD Professor of Pediatrics and Neurology,

UNSTRESSED VOWELS IN ENGLISH: DISTRIBUTIONS AND CONSEQUENCES Pter Szigetvri, Etvs Lornd

The Algonauts Project: Workshop 2019 Explaining the Human Visual Brain Day 2 Radoslaw Martin

Spinal Muscular Atrophy Landscape Analysis June 2019 SMA Market SMA drug pipeline includes

Should Universal Carrier Screening be Universal? Research funding from Natera Mary E Norton

DECEPTIVELY BENIGN- I have nothing to disclose APPEARING PROSTATE CANCER Peter A. Humphrey,

Emerging Roles of Obesity and Nutrition on the Aging Brain and Cognition Auriel A. Willette,